Renato Guzmán

2.5k total citations · 1 hit paper
10 papers, 1.8k citations indexed

About

Renato Guzmán is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Renato Guzmán has authored 10 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Hematology and 3 papers in Immunology. Recurrent topics in Renato Guzmán's work include Autoimmune and Inflammatory Disorders Research (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Renato Guzmán is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Renato Guzmán collaborates with scholars based in United States, Chile and Argentina. Renato Guzmán's co-authors include Mathew Thomas, Stephen Hall, Sandra Navarra, A Gallacher, Michelle Petri, William W. Freimuth, Roger A. Levy, Z. John Zhong, Joung-Liang Lan and C Tănăsescu and has published in prestigious journals such as The Lancet, Joint Bone Spine and JCR Journal of Clinical Rheumatology.

In The Last Decade

Renato Guzmán

9 papers receiving 1.7k citations

Hit Papers

Efficacy and safety of belimumab in patients with active ... 2011 2026 2016 2021 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
    2011 1.4k citations Sandra Navarra, Renato Guzmán et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renato Guzmán United States 5 1.4k 1.1k 767 174 170 10 1.8k
Douglas R. Hough United States 12 1.8k 1.3× 1.5k 1.4× 859 1.1× 131 0.8× 229 1.3× 16 2.4k
Agneta Zickert Sweden 28 1.6k 1.1× 1.2k 1.1× 363 0.5× 389 2.2× 229 1.3× 56 2.0k
Beulah Ji United States 14 1.3k 0.9× 880 0.8× 619 0.8× 311 1.8× 105 0.6× 31 1.6k
James D. McKay United States 9 1.4k 1.0× 908 0.8× 654 0.9× 78 0.4× 152 0.9× 13 1.7k
Simon Cooper United Kingdom 8 720 0.5× 733 0.7× 341 0.4× 91 0.5× 182 1.1× 28 1.2k
Asad Zoma United Kingdom 15 1.1k 0.8× 692 0.6× 398 0.5× 109 0.6× 252 1.5× 27 1.5k
M. L. Snaith United Kingdom 12 969 0.7× 571 0.5× 331 0.4× 122 0.7× 155 0.9× 14 1.2k
Juanita Romero‐Díaz Mexico 17 1.0k 0.7× 639 0.6× 272 0.4× 199 1.1× 158 0.9× 50 1.3k
Chee‐Seng Yee United Kingdom 14 985 0.7× 564 0.5× 298 0.4× 69 0.4× 218 1.3× 26 1.1k
Francisco Caeiro Argentina 11 889 0.6× 524 0.5× 187 0.2× 141 0.8× 137 0.8× 34 1.2k

Countries citing papers authored by Renato Guzmán

Since Specialization
Citations

This map shows the geographic impact of Renato Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Guzmán more than expected).

Fields of papers citing papers by Renato Guzmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Guzmán. The network helps show where Renato Guzmán may publish in the future.

Co-authorship network of co-authors of Renato Guzmán

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Guzmán. A scholar is included among the top collaborators of Renato Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Guzmán. Renato Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Castañeda‐Hernández, Gilberto, Zoltán Szekanecz, Eduardo Mysler, et al.. (2014). Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: Innovators, biosimilars, and intended copies. Joint Bone Spine. 81(6). 471–477. 41 indexed citations
4.
Pavelká, Karel, Rubén Burgos‐Vargas, Pedro C. Miranda, et al.. (2014). Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia. International Journal of Clinical Rheumatology. 9(5). 415–430. 4 indexed citations
5.
Guzmán, Renato, Ricardo Machado Xavier, J. Simón, et al.. (2013). Open-Label Observation of Addition of Etanercept Versus a Conventional Disease-Modifying Antirheumatic Drug in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy in the Latin American Region. JCR Journal of Clinical Rheumatology. 20(1). 25–33. 37 indexed citations
6.
Mysler, Eduardo, Alberto Spindler, Renato Guzmán, et al.. (2013). Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study. Arthritis & Rheumatism. 65(9). 2368–2379. 256 indexed citations
7.
Navarra, Sandra, Renato Guzmán, A Gallacher, et al.. (2011). Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. The Lancet. 377(9767). 721–731. 1401 indexed citations breakdown →
8.
Guzmán, Renato. (2006). Osteoporosis. Nutrición y tegidoóseo.Calcioelementeal.. Dialnet (Universidad de la Rioja). 20(1). 65–75. 1 indexed citations
9.
Sterba, Gary, et al.. (2006). Rituximab is Safe and Effective in Patients With Rheumatic Diseases. JCR Journal of Clinical Rheumatology. 12(2). S2–S3. 1 indexed citations
10.
Iglesias, Marta, Renato Guzmán, Octavio Martínez, José Félix Restrepo, & Antonio Iglesias. (2002). Inmunologia de la reproduccion. 170–180. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas R. Hough Breakdown of academic impact, for papers by Agneta Zickert Breakdown of academic impact, for papers by Beulah Ji Breakdown of academic impact, for papers by James D. McKay Breakdown of academic impact, for papers by Simon Cooper Breakdown of academic impact, for papers by Asad Zoma Breakdown of academic impact, for papers by M. L. Snaith Breakdown of academic impact, for papers by Juanita Romero‐Díaz Breakdown of academic impact, for papers by Chee‐Seng Yee Breakdown of academic impact, for papers by Francisco Caeiro
Rankless by CCL
2026